Stay updated on KZR-616 in PM and DM Open-label Extension Clinical Trial
Sign up to get notified when there's something new on the KZR-616 in PM and DM Open-label Extension Clinical Trial page.

Latest updates to the KZR-616 in PM and DM Open-label Extension Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedLocations are reorganized under a single Locations section, listing sites by state (CA, FL, KS, MD, MI, PA, TX) instead of separate per-state headings. The footer revision updated to Revision: v3.3.3 (replacing v3.3.2).SummaryDifference0.9%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedAdministrative updates were applied to the study record, including the addition of 'Last Update Posted (Estimated)' and 'Revision: v3.3.2'. Older results-related posting dates were removed.SummaryDifference0.3%

- Check40 days agoChange DetectedThe page no longer displays the government funding/operating status notice, a site-wide alert about data currency and operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange DetectedThe new screenshot shows only minor UI updates and wording changes on the Study Details page, with no alterations to core data such as eligibility criteria, enrollment, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check84 days agoChange DetectedAdded a government funding lapse notice and a new version tag (v3.2.0), replacing the old v3.1.0; this changes the core content and indicates updated operating status guidance.SummaryDifference5%

- Check91 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.1%

Stay in the know with updates to KZR-616 in PM and DM Open-label Extension Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KZR-616 in PM and DM Open-label Extension Clinical Trial page.